A randomized, placebo-controlled, two-period, crossover study to evaluate the effect of lurasidone HCL on oral contraceptive [norgestimate/ethinylestradiol] pharmacokinetics in healthy female subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Sep 2011
At a glance
- Drugs Ethinylestradiol/norgestimate; Lurasidone
- Indications Pregnancy; Psychotic disorders
- Focus Pharmacokinetics
- Sponsors Dainippon Sumitomo Pharma
- 22 Jan 2008 Status changed from recruiting to completed, in accordance with clinicaltrials.gov.
- 06 Nov 2007 New trial record.